Published in AIDS Weekly, March 20th, 2000
Researcher B. Masquelier and colleagues examined zidovudine resensitization and dual resistance to zidovudine/lamivudine in HIV-1 isolates from nucleoside reverse transcriptase (RT) inhibitor-experienced patients during selective pressure exerted by zidovudine/lamivudine combination therapy.
HIV-1 isolates from 29 patients receiving zidovudine/lamivudine combination therapy in the Delta Roll-Over Study were analyzed at entry and during a one year follow-up period for phenotypic susceptibility...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.